A glycoprotein from Spirometra erinaceieuropaei plerocercoids suppresses osteoclastogenesis and proinflammatory cytokine gene expression

International Journal for Parasitology

Volumn 35, Issue 13, 2005, Pages 1399-1406

  Kina, Yuriko ^a   Fukumoto, Soji ^a   Miura, Kazutoyo ^a   Tademoto, Sayuri ^a   Nunomura, Kozue ^a   Dirgahayu, Paramasari ^b   Hirai, Kazumitsu ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b SEBELAS MARET UNIVERSITY   (Indonesia)

Author keywords

Excretory secretory products; Glycoprotein; Inflammatory factor; Osteoclastogenesis; Receptor activator of nuclear factor B ligand (RANKL); Spirometra erinaceieuropaei

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CYTOKINE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

GENE EXPRESSION; IMMUNE RESPONSE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL COUNT; CELL LINEAGE; CESTODE; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; SPIROMETRA ERINACEIEUROPAEI;

ANIMALS; BIOLOGICAL FACTORS; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HELMINTH PROTEINS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPIROMETRA; TUMOR NECROSIS FACTOR-ALPHA;

SPIROMETRA ERINACEIEUROPAEI;

EID: 26944461583     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2005.05.012     Document Type: Article

References (38)

1. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342
2. N. Branza-Nichita, G. Negroiu, A.J. Petrescu, E.F. Garman, F.M. Platt, M.R. Wormald, R.A. Dwek, and S.M. Petrescu Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control J. Biol. Chem. 275 2000 8169 8175
3. P. Dirgahayu, S. Fukumoto, K. Miura, and K. Hirai Excretory/secretory products from plerocercoids of Spirometra erinaceieuropaei suppress the TNF-α gene expression by reducing phosphorylation of ERK1/2 and p38 MAPK in macrophages Int. J. Parasitol. 32 2002 1155 1162
4. P. Dirgahayu, S. Fukumoto, S. Tademoto, Y. Kina, and K. Hirai Excretory/secretory products from plerocercoids of Spirometra erinaceieuropaei suppress interleukin-1β gene expression in murine macrophages Int. J. Parasitol. 34 2004 577 584
5. A. Farooq, and M.M. Zhou Structure and regulation of MAPK phosphatases Cell. Signal. 16 2004 769 779
6. G.S. Firestein Evolving concepts of rheumatoid arthritis Nature 423 2003 356 361
7. S. Fukumoto, K. Hirai, T. Tanihata, Y. Ohmori, D.J. Stuehr, and T.A. Hamilton Excretory/secretory products from plerocercoids of Spirometra erinacei reduce iNOS and chemokine mRNA levels in peritoneal macrophages stimulated with cytokines and/or LPS Parasite Immunol. 19 1997 325 332
8. H.S. Goodridge, E.H. Wilson, W. Harnett, C.C. Campbell, M.M. Harnett, and F.Y. Liew Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae J. Immunol. 167 2001 940 945
9. H.S. Goodridge, F.A. Marshall, E.H. Wilson, K.M. Houston, F.Y. Liew, M.M. Harnett, and W. Harnett In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype Immunology 113 2004 491 498
10. W. Harnett, and M.M. Harnett Modulation of the host immune system by phosphorylcholine-containing glycoproteins secreted by parasitic filarial nematodes Biochim. Biophys. Acta 1539 2001 7 15
11. H. Hotokezaka, E. Sakai, K. Kanaoka, K. Saito, K. Matsuo, H. Kitaura, N. Yoshida, and K. Nakayama U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells J. Biol. Chem. 277 2002 47366 47372
12. S. Imai, and K. Fujita Molecules of parasites as immunomodulatory drugs Curr. Top. Med. Chem. 4 2004 539 552
13. T. Kagari, H. Doi, and T. Shimozato The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis J. Immunol. 169 2002 1459 1466
14. G. Ku, T. Faust, L.L. Lauffer, D.J. Livingston, and M.W. Harding Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice Cytokine 8 1996 377 386
15. S. Kudesia, D.B. Indira, D. Sarala, S. Vani, T.C. Yasha, P.N. Jayakumar, and S.K. Shankar Sparganosis of brain and spinal cord: unusual tapeworm infestation (report of two cases) Clin. Neurol. Neurosurg. 100 1998 148 152
16. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y.X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W.J. Boyle Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
17. S.E. Lee, K.M. Woo, S.Y. Kim, H.M. Kim, K. Kwack, Z.H. Lee, and H.H. Kim The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation Bone 30 2002 71 77
18. X. Li, N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda, and N. Takahashi p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function Endocrinology 143 2002 3105 3113
19. R.M. Maizels, and M. Yazdanbakhsh Immune regulation by helminth parasites: cellular and molecular mechanisms Nat. Rev. Immunol. 3 2003 733 744
20. R.M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M.D. Taylor, and J.E. Allen Helminth parasites - masters of regulation Immunol. Rev. 201 2004 89 116
21. M. Matsumoto, T. Sudo, T. Saito, H. Osada, and M. Tsujimoto Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL) J. Biol. Chem. 275 2000 31155 31161
22. I.B. McInnes, B.P. Leung, M. Harnett, J.A. Gracie, F.Y. Liew, and W. Harnett A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62 J. Immunol. 171 2003 2127 2133
23. R.K. Merkle, and R.D. Cummings Lectin affinity chromatography of glycopeptides Methods Enzymol. 138 1987 232 259
24. K. Miura, S. Fukumoto, P. Dirgahayu, and K. Hirai Excretory/secretory products from plerocercoids of Spirometra erinaceieuropaei suppress gene expressions and production of tumor necrosis factor-α in murine macrophages stimulated with lipopolysaccharide or lipoteichoic acid Int. J. Parasitol. 31 2001 39 47
25. T. Miyamoto, O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D.M. Anderson, and T. Suda Bifurcation of osteoclasts and dendritic cells from common progenitors Blood 98 2001 2544 2554
26. T. Raine, P. Zaccone, D.W. Dunne, and A. Cooke Can helminth antigens be exploited therapeutically to downregulate pathological Th1 responses? Curr. Opin. Invest. Drugs 5 2004 1184 1191
27. A. Rivollier, M. Mazzorana, J. Tebib, M. Piperno, T. Aitsiselmi, C. Rabourdin-Combe, P. Jurdic, and C. Servet-Delprat Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment Blood 104 2004 4029 4037
28. G.A. Rodan, and T.J. Martin Therapeutic approaches to bone diseases Science 289 2000 1508 1514
29. E. Romas, M.T. Gillespie, and T.J. Martin Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis Bone 30 2002 340 346
30. + macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia BioMed Central Immunol. 3 2002 15
31. R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, and L.G. Presta Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity J. Biol. Chem. 277 2002 26733 26740
32. J.B. Smith, and M.K. Haynes Rheumatoid arthritis-a molecular understanding Ann. Intern. Med. 136 2002 908 922
33. R.W. Summers, D.E. Elliott, J.F. Urban Jr., R. Thompson, and J.V. Weinstock Trichuris suis therapy in Crohn's disease Gut 54 2005 87 90
34. T. Tsuda, Y. Ikeda, and N. Taniguchi The Asn-420-linked sugar chain in human epidermal growth factor receptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain in controllable receptor activation J. Biol. Chem. 275 2000 21988 21994
35. R.J. van't Hof, and S.H. Ralston Nitric oxide and bone Immunology 103 2001 255 261
36. M.S. Wilson, and R.M. Maizels Regulation of allergy and autoimmunity in helminth infection Clin. Rev. Allergy Immunol. 26 2004 35 50
37. T. Yamane, T. Kunisada, and S. Hayashi Embryonic stem cells as a model for studying osteoclast lineage development Methods Mol. Biol. 185 2002 97 106
38. X. Zhong, R. Malhotra, R. Woodruff, and G. Guidotti Mammalian plasma membrane ecto-nucleoside triphosphate diphosphohydrolase 1, CD39, is not active intracellularly. The N-glycosylation state of CD39 correlates with surface activity and localization J. Biol. Chem. 276 2001 41518 41525